COVID-19 VACCINATION DEMAND SURVEY

2
MJ Ulrich
Over the past couple of years, the Boost Community has brought our members’ voices, like yours, to the forefront, highlighting challenges and successes of your work as you have strived to continue critical routine immunization services amidst the COVID-19 pandemic while at the same time, planning for and executing the rapid rollout of COVID-19 vaccines across your communities. As we plan and implement new programming to address the urgent concern of low vaccine demand as it relates to COVID-19 vaccines, we want to hear from you! We ask that you please complete this short survey (5-10 minutes) by February 18, 2022. to help us understand the current vaccine demand challenges in your country, identify ongoing programming and remaining gaps, and uncover new ideas to accelerate vaccine uptake. Take survey --> https://boost-community.typeform.com/to/yvzim3Vk
  • You must be logged in to reply to this topic.

LNCT Materials to Help you Make the Case for Investing in Immunization

Why We Need to Make a Case for Investment Maintaining a high performing immunization program requires sustained commitment and funding over time.  Ongoing communication and advocacy are needed to maintain investments and to stimulate additional investments to achieve health goals. Advocating for resources for immunization at national and sub-national levels requires demonstrating the health and … Continued

Read

Re-evaluating the Potential Impact and Cost-effectiveness of Rotavirus Vaccination in 73 Gavi Countries: A Modelling Study

 | Frédéric Debellut, Andrew Clark, Clint Pecenka, Jacqueline Tate, Ranju Baral, Colin Sanderson, et al.

Background Previous studies have found rotavirus vaccination to be highly cost-effective in low-income countries. However, updated evidence is now available for several inputs (ie, rotavirus disease mortality rates, rotavirus age distributions, vaccine timeliness, and vaccine efficacy by duration of follow-up), new rotavirus vaccines have entered the market, vaccine prices have decreased, and cost-effectiveness thresholds have … Continued

Read